M&A case study: Piedmont Animal Health sells to London-based company Dechra to commercialize products


In drug development, there comes a time when a therapeutic needs to be commercialized, and that time came this summer for Piedmont Animal Health.

Previous UnitedHealth lifts earnings outlook for third straight quarter
Next Colorado one of the housing markets most vulnerable to price declines across the country